Related Experiment Videos

[Childhood upper respiratory infection caused by Mycoplasma pneumoniae]

Ding Lu1, Shi-Qiang Liu, Li-Bao Zhuang

  • 1Department of Pediatrics, Shanghai No.8 People's Hospital, Shanghai 200233, China. luding146@sina.com

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|June 22, 2006
PubMed
Abstract

Insights

Mycoplasma pneumoniae (MP) is a common cause of upper respiratory infections (URI) in children, particularly those over one year old. MP-positive URI cases often present with cough and tonsillitis and have a higher risk of developing pneumonia.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Respiratory medicine

Context:

  • Acute upper respiratory infections (URI) are common in children.
  • Mycoplasma pneumoniae (MP) is a significant pathogen contributing to URIs.
  • Understanding MP prevalence and clinical impact in children is crucial for effective management.

Purpose:

  • To determine the prevalence of Mycoplasma pneumoniae (MP) in children with acute URI.
  • To describe the clinical characteristics and outcomes associated with MP infection in pediatric URI.
  • To compare MP prevalence and outcomes between different age groups and with non-infected controls.

Summary:

  • MP antibody was detected in 31.7% of children with acute URI versus 9.0% in controls.
  • MP infection was more prevalent in children over one year old.
  • Symptoms like cough and tonsillitis were more frequent in MP-positive cases, with a higher incidence of pneumonia (14.8% vs 7.0%).

Impact:

  • MP is identified as a primary pathogen in pediatric acute URI.
  • Pharyngotonsillitis is a predominant symptom of MP infection in children.
  • Children over one year old with MP infection face an increased risk of developing pneumonia.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: